Pacific Biosciences Of California reported $280.55M in Equity Capital and Reserves for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Accelerate Diagnostics AXDX:US -66364000 3.55M
Agilent A:US $ 4810M 6M
Bruker BRKR:US $ 981.7M 20.5M
Danaher DHR:US $ 42756M 2337M
Fluidigm FLDM:US $ 122.94M 16.11M
General Electric GE:US $ 33487M 98M
Genmark Diagnostics GNMK:US $ 94.2M 0.24M
Illumina ILMN:US $ 4922M 228M
Luminex LMNX:US $ 488.05M 29.66M
Myriad Genetics MYGN:US $ 881M 28.3M
Nanostring Technologies NSTG:US $ 236.39M 70.56M
Oxford Immunotec Global OXFD:US $ 191.26M 2.37M
Pacific Biosciences Of California PACB:US $ 280.55M 54.94M
Perkinelmer PKI:US $ 4239.81M 237.5M
Quidel QDEL:US $ 1489.71M 157.01M
Thermo Fisher Scientific TMO:US $ 36854M 1796M
Waters WAT:US $ 230.96M 1.18M